Interviews

GSK Launches New Platform for Tracking Adult Vaccination Rates

by Veronica Salib

As healthcare professionals and public health leaders continue expressing concerns about adult vaccination rates post-pandemic, GSK has launched its new COiMMUNITY Initiative to improve adult vaccine uptake. As part of the initiative, GSK...

How Inflation, Competition, Biosimilars Affect Prescription Drug Costs

by Editorial Staff

As the inflation rate continues to rise, the healthcare industry — like every other industry — is taxed with extraordinarily high costs. Rising drug prices have caused increased healthcare expenditures and out-of-pocket costs....

Examining Challenges and the Potential of Integrating AI in Healthcare

by Alivia Kaylor

As the healthcare industry continues to embrace artificial intelligence (AI), experts are examining the challenges that hamstring the adoption of this transformative technology.   Understanding the challenges and potential of...

Addressing Clinical Trial Challenges and High Drug Development Costs

by Editorial Staff

The drug development process is a notably tricky component of the pharmaceutical industry, accounting for the most time and money required to get a drug to market. Across the United States, the average spending on drug development is...

FNIH Enhances Rare Disease Research by Adding 8 Diseases to BGTC

by Veronica Salib

On May 16, 2023, the Foundation for the National Institutes of Health (FNIH) announced eight rare diseases to be explored by the Accelerating Medicines Partnership Bespoke Gene Therapy Consortium (AMP BGTC). As one of the newest additions...

Oral Ketamine Treatment: An Alternative to Ketamine Infusions

by Veronica Salib

Data from the WHO estimates that 230 million people globally have depression. Although many traditional treatments exist for depression, roughly 33% of people do not respond to medications. As a result, researchers have searched for...

Advancing Health Equity with Clinical Trial Diversity: Key Strategies

by Veronica Salib

Clinical trials are currently the gold standard for proving the efficacy and safety of new treatments for regulatory approval. Globally, clinical trial data supports medical decisions and drug development. Each year, hundreds of thousands...

Drug Shortages: A Growing Concern for the Healthcare Industry Worldwide

by Alivia Kaylor

Drug shortages have become a growing concern for the healthcare industry worldwide as patients are left without essential medications, and healthcare providers struggle to find alternative treatments. The problem has been rising for...

A New Era in Medicine: The Therapeutic Promise of HMO-Based Medications

by Alivia Kaylor

Human breast milk has long been recognized as the optimal source of infant nutrition, providing essential nutrients and antibodies that promote growth and protect against infection. However, research has revealed that breast milk contains...

Minimizing Prescription Abandonment and Nonadherence with Digital Tools

by Veronica Salib

Although prescription adherence is widely regarded as one of the most critical indicators for health outcomes, the rate of nonadherence and abandonment have continued to rise across the United States, leading to thousands of deaths and...

Nectin Therapeutics Collaborates with Merck on Cancer Treatment

by Veronica Salib

Earlier this year, Nectin Therapeutics Ltd, a clinical biotechnology company, announced a collaboration with Merck, a leading global pharmaceutical company, to develop a treatment regimen for cancer patients. The clinical trial combines a...

Analyzing Returns on Investment from Pharmaceutical Innovation

by Veronica Salib

In an annual report focused on the return on investment (ROI) from pharmaceutical innovation, Deloitte analyzed research and development (R&D) in the pharmaceutical industry and the resulting outcomes throughout 2022. Considering the...

Finding Solutions for Drug Shortages: Short and Long-Term Management

by Veronica Salib

The healthcare industry has experienced more shortages in the past few years than ever. In addition to prescription drug shortages, the sector has seen shortages in contrast dye and helium, impacting imaging, animal test subjects for...

Understanding Multiple Sclerosis and the Role of Specialty Care

by Alivia Kaylor

Multiple sclerosis is an immune-mediated disease that affects nearly 1 million people in the United States and over 2.8 million worldwide. Given the complexity of treatment, specialty care teams play a vital role in disease management by...

Analyzing 2023 Drug List Price Increases by Pharmaceutical Companies

by Veronica Salib

In January of this year, 46brooklyn, an Ohio-based nonprofit focusing on drug pricing data in the United States, revealed its annual drug pricing data report for 2023. The organization uses and analyzes proprietary data to help shed light...

The Importance of Delaying the Onset of Type 1 Diabetes with New Treatment

by Alivia Kaylor

With a new FDA-approved immunotherapy treatment designed to delay the onset of type 1 diabetes (T1D), patients — 8 years or older — can enjoy more years without the physical and financial burdens of living with...

Identifying and Preventing Prescriber Identity Theft in the Digital Era

by Veronica Salib

Between 2013 and 2015, the Federal Trade Commission (FTC) identified nearly 10,000 cases of prescriber identity theft. An article by the Cooperative of American Physicians states that 10% of prescribers have had their Drug Enforcement...

Drug Repurposing May Benefit Rare Disease, Considerations, and Caveats

by Veronica Salib

The Orphan Drug Act of 1983 defines a rare disease as a medical condition that impacts less than 200,000 people in the United States. Despite the restrictive nature of this definition, the Genetic and Rare Diseases Information Center of...

How Naloxone Co-Prescribing Laws Can Facilitate Opioid Education

by Veronica Salib

Fueled by deceit from pharmaceutical companies and over-prescription, the opioid epidemic has continued to impact thousands of lives. Throughout recent years, public health organizations and healthcare professionals have been working to...

RSV, How Pharmacists Can Help Patients Prevent and Manage Infections

by Alivia Kaylor

As respiratory syncytial virus (RSV), influenza (flu), and COVID-19 cases surge across the United States, pharmacists are encouraged to use their advanced healthcare role to educate patients and caregivers about preventing the transmission...